Global Viral Vector CDMO Services Supply, Demand and Key Producers, 2023-2029
The global Viral Vector CDMO Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.
CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.
CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.
This report studies the global Viral Vector CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Vector CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Vector CDMO Services total market, 2018-2029, (USD Million)
Global Viral Vector CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Viral Vector CDMO Services total market, key domestic companies and share, (USD Million)
Global Viral Vector CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Viral Vector CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Viral Vector CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Viral Vector CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics?MolMed? and Gene Universal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Vector CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viral Vector CDMO Services Market, By Region:
1. How big is the global Viral Vector CDMO Services market?
2. What is the demand of the global Viral Vector CDMO Services market?
3. What is the year over year growth of the global Viral Vector CDMO Services market?
4. What is the total value of the global Viral Vector CDMO Services market?
5. Who are the major players in the global Viral Vector CDMO Services market?
Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.
CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.
CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.
This report studies the global Viral Vector CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Vector CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Vector CDMO Services total market, 2018-2029, (USD Million)
Global Viral Vector CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Viral Vector CDMO Services total market, key domestic companies and share, (USD Million)
Global Viral Vector CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Viral Vector CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Viral Vector CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Viral Vector CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics?MolMed? and Gene Universal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Vector CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viral Vector CDMO Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- AAV
- Lentivirus
- Adenovirus
- HSV
- Others
- Vaccine Development
- Gene Therapy
- Academic Scientific Research Institution
- Others
- Thermo Fisher Scientific
- Lonza
- Catalent
- Charles River
- Merck
- SK pharmteco
- Oxford Biomedica
- AGC Biologics?MolMed?
- Gene Universal
- Polyplus (Sartorius)
- CCRM
- FUJIFILM Diosynth Biotechnologies
- Biovian
- Miltenyi Bioindustry
- Aldevron
- Takara Bio
- Yposkesi
- Genezen
- GenScript ProBio
- EurekaBio
- Obio Technology
- GeneSail Biotech
- VectorBuilder
- WuXi ATU
- Ubrigene
- Porton Biologics
- Pharmaron
- PackGene Biotechnology
- Hillgene
- Asymchem
- Exthera
- Flash Therapeutics
- VIVEBiotech
- FinVector
- uBriGene
- Eurogentec
- VGXI
1. How big is the global Viral Vector CDMO Services market?
2. What is the demand of the global Viral Vector CDMO Services market?
3. What is the year over year growth of the global Viral Vector CDMO Services market?
4. What is the total value of the global Viral Vector CDMO Services market?
5. Who are the major players in the global Viral Vector CDMO Services market?
1 SUPPLY SUMMARY
1.1 Viral Vector CDMO Services Introduction
1.2 World Viral Vector CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Viral Vector CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Viral Vector CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Viral Vector CDMO Services Market Size (2018-2029)
1.3.3 China Viral Vector CDMO Services Market Size (2018-2029)
1.3.4 Europe Viral Vector CDMO Services Market Size (2018-2029)
1.3.5 Japan Viral Vector CDMO Services Market Size (2018-2029)
1.3.6 South Korea Viral Vector CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Viral Vector CDMO Services Market Size (2018-2029)
1.3.8 India Viral Vector CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Vector CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Vector CDMO Services Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Vector CDMO Services Consumption Value (2018-2029)
2.2 World Viral Vector CDMO Services Consumption Value by Region
2.2.1 World Viral Vector CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Viral Vector CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Viral Vector CDMO Services Consumption Value (2018-2029)
2.4 China Viral Vector CDMO Services Consumption Value (2018-2029)
2.5 Europe Viral Vector CDMO Services Consumption Value (2018-2029)
2.6 Japan Viral Vector CDMO Services Consumption Value (2018-2029)
2.7 South Korea Viral Vector CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Viral Vector CDMO Services Consumption Value (2018-2029)
2.9 India Viral Vector CDMO Services Consumption Value (2018-2029)
3 WORLD VIRAL VECTOR CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Viral Vector CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Viral Vector CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Viral Vector CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Viral Vector CDMO Services in 2022
3.3 Viral Vector CDMO Services Company Evaluation Quadrant
3.4 Viral Vector CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Viral Vector CDMO Services Market: Region Footprint
3.4.2 Viral Vector CDMO Services Market: Company Product Type Footprint
3.4.3 Viral Vector CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Viral Vector CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Viral Vector CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Viral Vector CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Viral Vector CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Viral Vector CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viral Vector CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Viral Vector CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Viral Vector CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Viral Vector CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Viral Vector CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Viral Vector CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Viral Vector CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Viral Vector CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Vector CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 AAV
5.2.2 Lentivirus
5.2.3 Adenovirus
5.2.4 HSV
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Viral Vector CDMO Services Market Size by Type (2018-2023)
5.3.2 World Viral Vector CDMO Services Market Size by Type (2024-2029)
5.3.3 World Viral Vector CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Vector CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Vaccine Development
6.2.2 Gene Therapy
6.2.3 Academic Scientific Research Institution
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Viral Vector CDMO Services Market Size by Application (2018-2023)
6.3.2 World Viral Vector CDMO Services Market Size by Application (2024-2029)
6.3.3 World Viral Vector CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific Viral Vector CDMO Services Product and Services
7.1.4 Thermo Fisher Scientific Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Lonza
7.2.1 Lonza Details
7.2.2 Lonza Major Business
7.2.3 Lonza Viral Vector CDMO Services Product and Services
7.2.4 Lonza Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Recent Developments/Updates
7.2.6 Lonza Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Viral Vector CDMO Services Product and Services
7.3.4 Catalent Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Charles River
7.4.1 Charles River Details
7.4.2 Charles River Major Business
7.4.3 Charles River Viral Vector CDMO Services Product and Services
7.4.4 Charles River Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Charles River Recent Developments/Updates
7.4.6 Charles River Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Viral Vector CDMO Services Product and Services
7.5.4 Merck Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 SK pharmteco
7.6.1 SK pharmteco Details
7.6.2 SK pharmteco Major Business
7.6.3 SK pharmteco Viral Vector CDMO Services Product and Services
7.6.4 SK pharmteco Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 SK pharmteco Recent Developments/Updates
7.6.6 SK pharmteco Competitive Strengths & Weaknesses
7.7 Oxford Biomedica
7.7.1 Oxford Biomedica Details
7.7.2 Oxford Biomedica Major Business
7.7.3 Oxford Biomedica Viral Vector CDMO Services Product and Services
7.7.4 Oxford Biomedica Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Oxford Biomedica Recent Developments/Updates
7.7.6 Oxford Biomedica Competitive Strengths & Weaknesses
7.8 AGC Biologics?MolMed?
7.8.1 AGC Biologics?MolMed? Details
7.8.2 AGC Biologics?MolMed? Major Business
7.8.3 AGC Biologics?MolMed? Viral Vector CDMO Services Product and Services
7.8.4 AGC Biologics?MolMed? Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 AGC Biologics?MolMed? Recent Developments/Updates
7.8.6 AGC Biologics?MolMed? Competitive Strengths & Weaknesses
7.9 Gene Universal
7.9.1 Gene Universal Details
7.9.2 Gene Universal Major Business
7.9.3 Gene Universal Viral Vector CDMO Services Product and Services
7.9.4 Gene Universal Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Gene Universal Recent Developments/Updates
7.9.6 Gene Universal Competitive Strengths & Weaknesses
7.10 Polyplus (Sartorius)
7.10.1 Polyplus (Sartorius) Details
7.10.2 Polyplus (Sartorius) Major Business
7.10.3 Polyplus (Sartorius) Viral Vector CDMO Services Product and Services
7.10.4 Polyplus (Sartorius) Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Polyplus (Sartorius) Recent Developments/Updates
7.10.6 Polyplus (Sartorius) Competitive Strengths & Weaknesses
7.11 CCRM
7.11.1 CCRM Details
7.11.2 CCRM Major Business
7.11.3 CCRM Viral Vector CDMO Services Product and Services
7.11.4 CCRM Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CCRM Recent Developments/Updates
7.11.6 CCRM Competitive Strengths & Weaknesses
7.12 FUJIFILM Diosynth Biotechnologies
7.12.1 FUJIFILM Diosynth Biotechnologies Details
7.12.2 FUJIFILM Diosynth Biotechnologies Major Business
7.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Services
7.12.4 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.12.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.13 Biovian
7.13.1 Biovian Details
7.13.2 Biovian Major Business
7.13.3 Biovian Viral Vector CDMO Services Product and Services
7.13.4 Biovian Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Biovian Recent Developments/Updates
7.13.6 Biovian Competitive Strengths & Weaknesses
7.14 Miltenyi Bioindustry
7.14.1 Miltenyi Bioindustry Details
7.14.2 Miltenyi Bioindustry Major Business
7.14.3 Miltenyi Bioindustry Viral Vector CDMO Services Product and Services
7.14.4 Miltenyi Bioindustry Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Miltenyi Bioindustry Recent Developments/Updates
7.14.6 Miltenyi Bioindustry Competitive Strengths & Weaknesses
7.15 Aldevron
7.15.1 Aldevron Details
7.15.2 Aldevron Major Business
7.15.3 Aldevron Viral Vector CDMO Services Product and Services
7.15.4 Aldevron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Aldevron Recent Developments/Updates
7.15.6 Aldevron Competitive Strengths & Weaknesses
7.16 Takara Bio
7.16.1 Takara Bio Details
7.16.2 Takara Bio Major Business
7.16.3 Takara Bio Viral Vector CDMO Services Product and Services
7.16.4 Takara Bio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Takara Bio Recent Developments/Updates
7.16.6 Takara Bio Competitive Strengths & Weaknesses
7.17 Yposkesi
7.17.1 Yposkesi Details
7.17.2 Yposkesi Major Business
7.17.3 Yposkesi Viral Vector CDMO Services Product and Services
7.17.4 Yposkesi Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Yposkesi Recent Developments/Updates
7.17.6 Yposkesi Competitive Strengths & Weaknesses
7.18 Genezen
7.18.1 Genezen Details
7.18.2 Genezen Major Business
7.18.3 Genezen Viral Vector CDMO Services Product and Services
7.18.4 Genezen Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Genezen Recent Developments/Updates
7.18.6 Genezen Competitive Strengths & Weaknesses
7.19 GenScript ProBio
7.19.1 GenScript ProBio Details
7.19.2 GenScript ProBio Major Business
7.19.3 GenScript ProBio Viral Vector CDMO Services Product and Services
7.19.4 GenScript ProBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 GenScript ProBio Recent Developments/Updates
7.19.6 GenScript ProBio Competitive Strengths & Weaknesses
7.20 EurekaBio
7.20.1 EurekaBio Details
7.20.2 EurekaBio Major Business
7.20.3 EurekaBio Viral Vector CDMO Services Product and Services
7.20.4 EurekaBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 EurekaBio Recent Developments/Updates
7.20.6 EurekaBio Competitive Strengths & Weaknesses
7.21 Obio Technology
7.21.1 Obio Technology Details
7.21.2 Obio Technology Major Business
7.21.3 Obio Technology Viral Vector CDMO Services Product and Services
7.21.4 Obio Technology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Obio Technology Recent Developments/Updates
7.21.6 Obio Technology Competitive Strengths & Weaknesses
7.22 GeneSail Biotech
7.22.1 GeneSail Biotech Details
7.22.2 GeneSail Biotech Major Business
7.22.3 GeneSail Biotech Viral Vector CDMO Services Product and Services
7.22.4 GeneSail Biotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 GeneSail Biotech Recent Developments/Updates
7.22.6 GeneSail Biotech Competitive Strengths & Weaknesses
7.23 VectorBuilder
7.23.1 VectorBuilder Details
7.23.2 VectorBuilder Major Business
7.23.3 VectorBuilder Viral Vector CDMO Services Product and Services
7.23.4 VectorBuilder Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 VectorBuilder Recent Developments/Updates
7.23.6 VectorBuilder Competitive Strengths & Weaknesses
7.24 WuXi ATU
7.24.1 WuXi ATU Details
7.24.2 WuXi ATU Major Business
7.24.3 WuXi ATU Viral Vector CDMO Services Product and Services
7.24.4 WuXi ATU Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 WuXi ATU Recent Developments/Updates
7.24.6 WuXi ATU Competitive Strengths & Weaknesses
7.25 Ubrigene
7.25.1 Ubrigene Details
7.25.2 Ubrigene Major Business
7.25.3 Ubrigene Viral Vector CDMO Services Product and Services
7.25.4 Ubrigene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Ubrigene Recent Developments/Updates
7.25.6 Ubrigene Competitive Strengths & Weaknesses
7.26 Porton Biologics
7.26.1 Porton Biologics Details
7.26.2 Porton Biologics Major Business
7.26.3 Porton Biologics Viral Vector CDMO Services Product and Services
7.26.4 Porton Biologics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Porton Biologics Recent Developments/Updates
7.26.6 Porton Biologics Competitive Strengths & Weaknesses
7.27 Pharmaron
7.27.1 Pharmaron Details
7.27.2 Pharmaron Major Business
7.27.3 Pharmaron Viral Vector CDMO Services Product and Services
7.27.4 Pharmaron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Pharmaron Recent Developments/Updates
7.27.6 Pharmaron Competitive Strengths & Weaknesses
7.28 PackGene Biotechnology
7.28.1 PackGene Biotechnology Details
7.28.2 PackGene Biotechnology Major Business
7.28.3 PackGene Biotechnology Viral Vector CDMO Services Product and Services
7.28.4 PackGene Biotechnology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 PackGene Biotechnology Recent Developments/Updates
7.28.6 PackGene Biotechnology Competitive Strengths & Weaknesses
7.29 Hillgene
7.29.1 Hillgene Details
7.29.2 Hillgene Major Business
7.29.3 Hillgene Viral Vector CDMO Services Product and Services
7.29.4 Hillgene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 Hillgene Recent Developments/Updates
7.29.6 Hillgene Competitive Strengths & Weaknesses
7.30 Asymchem
7.30.1 Asymchem Details
7.30.2 Asymchem Major Business
7.30.3 Asymchem Viral Vector CDMO Services Product and Services
7.30.4 Asymchem Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.30.5 Asymchem Recent Developments/Updates
7.30.6 Asymchem Competitive Strengths & Weaknesses
7.31 Exthera
7.31.1 Exthera Details
7.31.2 Exthera Major Business
7.31.3 Exthera Viral Vector CDMO Services Product and Services
7.31.4 Exthera Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.31.5 Exthera Recent Developments/Updates
7.31.6 Exthera Competitive Strengths & Weaknesses
7.32 Flash Therapeutics
7.32.1 Flash Therapeutics Details
7.32.2 Flash Therapeutics Major Business
7.32.3 Flash Therapeutics Viral Vector CDMO Services Product and Services
7.32.4 Flash Therapeutics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.32.5 Flash Therapeutics Recent Developments/Updates
7.32.6 Flash Therapeutics Competitive Strengths & Weaknesses
7.33 VIVEBiotech
7.33.1 VIVEBiotech Details
7.33.2 VIVEBiotech Major Business
7.33.3 VIVEBiotech Viral Vector CDMO Services Product and Services
7.33.4 VIVEBiotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.33.5 VIVEBiotech Recent Developments/Updates
7.33.6 VIVEBiotech Competitive Strengths & Weaknesses
7.34 FinVector
7.34.1 FinVector Details
7.34.2 FinVector Major Business
7.34.3 FinVector Viral Vector CDMO Services Product and Services
7.34.4 FinVector Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.34.5 FinVector Recent Developments/Updates
7.34.6 FinVector Competitive Strengths & Weaknesses
7.35 uBriGene
7.35.1 uBriGene Details
7.35.2 uBriGene Major Business
7.35.3 uBriGene Viral Vector CDMO Services Product and Services
7.35.4 uBriGene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.35.5 uBriGene Recent Developments/Updates
7.35.6 uBriGene Competitive Strengths & Weaknesses
7.36 Eurogentec
7.36.1 Eurogentec Details
7.36.2 Eurogentec Major Business
7.36.3 Eurogentec Viral Vector CDMO Services Product and Services
7.36.4 Eurogentec Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.36.5 Eurogentec Recent Developments/Updates
7.36.6 Eurogentec Competitive Strengths & Weaknesses
7.37 VGXI
7.37.1 VGXI Details
7.37.2 VGXI Major Business
7.37.3 VGXI Viral Vector CDMO Services Product and Services
7.37.4 VGXI Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.37.5 VGXI Recent Developments/Updates
7.37.6 VGXI Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Vector CDMO Services Industry Chain
8.2 Viral Vector CDMO Services Upstream Analysis
8.3 Viral Vector CDMO Services Midstream Analysis
8.4 Viral Vector CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Viral Vector CDMO Services Introduction
1.2 World Viral Vector CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Viral Vector CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Viral Vector CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Viral Vector CDMO Services Market Size (2018-2029)
1.3.3 China Viral Vector CDMO Services Market Size (2018-2029)
1.3.4 Europe Viral Vector CDMO Services Market Size (2018-2029)
1.3.5 Japan Viral Vector CDMO Services Market Size (2018-2029)
1.3.6 South Korea Viral Vector CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Viral Vector CDMO Services Market Size (2018-2029)
1.3.8 India Viral Vector CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Vector CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Vector CDMO Services Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Vector CDMO Services Consumption Value (2018-2029)
2.2 World Viral Vector CDMO Services Consumption Value by Region
2.2.1 World Viral Vector CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Viral Vector CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Viral Vector CDMO Services Consumption Value (2018-2029)
2.4 China Viral Vector CDMO Services Consumption Value (2018-2029)
2.5 Europe Viral Vector CDMO Services Consumption Value (2018-2029)
2.6 Japan Viral Vector CDMO Services Consumption Value (2018-2029)
2.7 South Korea Viral Vector CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Viral Vector CDMO Services Consumption Value (2018-2029)
2.9 India Viral Vector CDMO Services Consumption Value (2018-2029)
3 WORLD VIRAL VECTOR CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Viral Vector CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Viral Vector CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Viral Vector CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Viral Vector CDMO Services in 2022
3.3 Viral Vector CDMO Services Company Evaluation Quadrant
3.4 Viral Vector CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Viral Vector CDMO Services Market: Region Footprint
3.4.2 Viral Vector CDMO Services Market: Company Product Type Footprint
3.4.3 Viral Vector CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Viral Vector CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Viral Vector CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Viral Vector CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Viral Vector CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Viral Vector CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viral Vector CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Viral Vector CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Viral Vector CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Viral Vector CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Viral Vector CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Viral Vector CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Viral Vector CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Viral Vector CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Vector CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 AAV
5.2.2 Lentivirus
5.2.3 Adenovirus
5.2.4 HSV
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Viral Vector CDMO Services Market Size by Type (2018-2023)
5.3.2 World Viral Vector CDMO Services Market Size by Type (2024-2029)
5.3.3 World Viral Vector CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Vector CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Vaccine Development
6.2.2 Gene Therapy
6.2.3 Academic Scientific Research Institution
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Viral Vector CDMO Services Market Size by Application (2018-2023)
6.3.2 World Viral Vector CDMO Services Market Size by Application (2024-2029)
6.3.3 World Viral Vector CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific Viral Vector CDMO Services Product and Services
7.1.4 Thermo Fisher Scientific Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Lonza
7.2.1 Lonza Details
7.2.2 Lonza Major Business
7.2.3 Lonza Viral Vector CDMO Services Product and Services
7.2.4 Lonza Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Recent Developments/Updates
7.2.6 Lonza Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Viral Vector CDMO Services Product and Services
7.3.4 Catalent Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Charles River
7.4.1 Charles River Details
7.4.2 Charles River Major Business
7.4.3 Charles River Viral Vector CDMO Services Product and Services
7.4.4 Charles River Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Charles River Recent Developments/Updates
7.4.6 Charles River Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Viral Vector CDMO Services Product and Services
7.5.4 Merck Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 SK pharmteco
7.6.1 SK pharmteco Details
7.6.2 SK pharmteco Major Business
7.6.3 SK pharmteco Viral Vector CDMO Services Product and Services
7.6.4 SK pharmteco Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 SK pharmteco Recent Developments/Updates
7.6.6 SK pharmteco Competitive Strengths & Weaknesses
7.7 Oxford Biomedica
7.7.1 Oxford Biomedica Details
7.7.2 Oxford Biomedica Major Business
7.7.3 Oxford Biomedica Viral Vector CDMO Services Product and Services
7.7.4 Oxford Biomedica Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Oxford Biomedica Recent Developments/Updates
7.7.6 Oxford Biomedica Competitive Strengths & Weaknesses
7.8 AGC Biologics?MolMed?
7.8.1 AGC Biologics?MolMed? Details
7.8.2 AGC Biologics?MolMed? Major Business
7.8.3 AGC Biologics?MolMed? Viral Vector CDMO Services Product and Services
7.8.4 AGC Biologics?MolMed? Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 AGC Biologics?MolMed? Recent Developments/Updates
7.8.6 AGC Biologics?MolMed? Competitive Strengths & Weaknesses
7.9 Gene Universal
7.9.1 Gene Universal Details
7.9.2 Gene Universal Major Business
7.9.3 Gene Universal Viral Vector CDMO Services Product and Services
7.9.4 Gene Universal Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Gene Universal Recent Developments/Updates
7.9.6 Gene Universal Competitive Strengths & Weaknesses
7.10 Polyplus (Sartorius)
7.10.1 Polyplus (Sartorius) Details
7.10.2 Polyplus (Sartorius) Major Business
7.10.3 Polyplus (Sartorius) Viral Vector CDMO Services Product and Services
7.10.4 Polyplus (Sartorius) Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Polyplus (Sartorius) Recent Developments/Updates
7.10.6 Polyplus (Sartorius) Competitive Strengths & Weaknesses
7.11 CCRM
7.11.1 CCRM Details
7.11.2 CCRM Major Business
7.11.3 CCRM Viral Vector CDMO Services Product and Services
7.11.4 CCRM Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CCRM Recent Developments/Updates
7.11.6 CCRM Competitive Strengths & Weaknesses
7.12 FUJIFILM Diosynth Biotechnologies
7.12.1 FUJIFILM Diosynth Biotechnologies Details
7.12.2 FUJIFILM Diosynth Biotechnologies Major Business
7.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Services
7.12.4 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.12.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.13 Biovian
7.13.1 Biovian Details
7.13.2 Biovian Major Business
7.13.3 Biovian Viral Vector CDMO Services Product and Services
7.13.4 Biovian Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Biovian Recent Developments/Updates
7.13.6 Biovian Competitive Strengths & Weaknesses
7.14 Miltenyi Bioindustry
7.14.1 Miltenyi Bioindustry Details
7.14.2 Miltenyi Bioindustry Major Business
7.14.3 Miltenyi Bioindustry Viral Vector CDMO Services Product and Services
7.14.4 Miltenyi Bioindustry Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Miltenyi Bioindustry Recent Developments/Updates
7.14.6 Miltenyi Bioindustry Competitive Strengths & Weaknesses
7.15 Aldevron
7.15.1 Aldevron Details
7.15.2 Aldevron Major Business
7.15.3 Aldevron Viral Vector CDMO Services Product and Services
7.15.4 Aldevron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Aldevron Recent Developments/Updates
7.15.6 Aldevron Competitive Strengths & Weaknesses
7.16 Takara Bio
7.16.1 Takara Bio Details
7.16.2 Takara Bio Major Business
7.16.3 Takara Bio Viral Vector CDMO Services Product and Services
7.16.4 Takara Bio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Takara Bio Recent Developments/Updates
7.16.6 Takara Bio Competitive Strengths & Weaknesses
7.17 Yposkesi
7.17.1 Yposkesi Details
7.17.2 Yposkesi Major Business
7.17.3 Yposkesi Viral Vector CDMO Services Product and Services
7.17.4 Yposkesi Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Yposkesi Recent Developments/Updates
7.17.6 Yposkesi Competitive Strengths & Weaknesses
7.18 Genezen
7.18.1 Genezen Details
7.18.2 Genezen Major Business
7.18.3 Genezen Viral Vector CDMO Services Product and Services
7.18.4 Genezen Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Genezen Recent Developments/Updates
7.18.6 Genezen Competitive Strengths & Weaknesses
7.19 GenScript ProBio
7.19.1 GenScript ProBio Details
7.19.2 GenScript ProBio Major Business
7.19.3 GenScript ProBio Viral Vector CDMO Services Product and Services
7.19.4 GenScript ProBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 GenScript ProBio Recent Developments/Updates
7.19.6 GenScript ProBio Competitive Strengths & Weaknesses
7.20 EurekaBio
7.20.1 EurekaBio Details
7.20.2 EurekaBio Major Business
7.20.3 EurekaBio Viral Vector CDMO Services Product and Services
7.20.4 EurekaBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 EurekaBio Recent Developments/Updates
7.20.6 EurekaBio Competitive Strengths & Weaknesses
7.21 Obio Technology
7.21.1 Obio Technology Details
7.21.2 Obio Technology Major Business
7.21.3 Obio Technology Viral Vector CDMO Services Product and Services
7.21.4 Obio Technology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Obio Technology Recent Developments/Updates
7.21.6 Obio Technology Competitive Strengths & Weaknesses
7.22 GeneSail Biotech
7.22.1 GeneSail Biotech Details
7.22.2 GeneSail Biotech Major Business
7.22.3 GeneSail Biotech Viral Vector CDMO Services Product and Services
7.22.4 GeneSail Biotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 GeneSail Biotech Recent Developments/Updates
7.22.6 GeneSail Biotech Competitive Strengths & Weaknesses
7.23 VectorBuilder
7.23.1 VectorBuilder Details
7.23.2 VectorBuilder Major Business
7.23.3 VectorBuilder Viral Vector CDMO Services Product and Services
7.23.4 VectorBuilder Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 VectorBuilder Recent Developments/Updates
7.23.6 VectorBuilder Competitive Strengths & Weaknesses
7.24 WuXi ATU
7.24.1 WuXi ATU Details
7.24.2 WuXi ATU Major Business
7.24.3 WuXi ATU Viral Vector CDMO Services Product and Services
7.24.4 WuXi ATU Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 WuXi ATU Recent Developments/Updates
7.24.6 WuXi ATU Competitive Strengths & Weaknesses
7.25 Ubrigene
7.25.1 Ubrigene Details
7.25.2 Ubrigene Major Business
7.25.3 Ubrigene Viral Vector CDMO Services Product and Services
7.25.4 Ubrigene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Ubrigene Recent Developments/Updates
7.25.6 Ubrigene Competitive Strengths & Weaknesses
7.26 Porton Biologics
7.26.1 Porton Biologics Details
7.26.2 Porton Biologics Major Business
7.26.3 Porton Biologics Viral Vector CDMO Services Product and Services
7.26.4 Porton Biologics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Porton Biologics Recent Developments/Updates
7.26.6 Porton Biologics Competitive Strengths & Weaknesses
7.27 Pharmaron
7.27.1 Pharmaron Details
7.27.2 Pharmaron Major Business
7.27.3 Pharmaron Viral Vector CDMO Services Product and Services
7.27.4 Pharmaron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Pharmaron Recent Developments/Updates
7.27.6 Pharmaron Competitive Strengths & Weaknesses
7.28 PackGene Biotechnology
7.28.1 PackGene Biotechnology Details
7.28.2 PackGene Biotechnology Major Business
7.28.3 PackGene Biotechnology Viral Vector CDMO Services Product and Services
7.28.4 PackGene Biotechnology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 PackGene Biotechnology Recent Developments/Updates
7.28.6 PackGene Biotechnology Competitive Strengths & Weaknesses
7.29 Hillgene
7.29.1 Hillgene Details
7.29.2 Hillgene Major Business
7.29.3 Hillgene Viral Vector CDMO Services Product and Services
7.29.4 Hillgene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 Hillgene Recent Developments/Updates
7.29.6 Hillgene Competitive Strengths & Weaknesses
7.30 Asymchem
7.30.1 Asymchem Details
7.30.2 Asymchem Major Business
7.30.3 Asymchem Viral Vector CDMO Services Product and Services
7.30.4 Asymchem Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.30.5 Asymchem Recent Developments/Updates
7.30.6 Asymchem Competitive Strengths & Weaknesses
7.31 Exthera
7.31.1 Exthera Details
7.31.2 Exthera Major Business
7.31.3 Exthera Viral Vector CDMO Services Product and Services
7.31.4 Exthera Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.31.5 Exthera Recent Developments/Updates
7.31.6 Exthera Competitive Strengths & Weaknesses
7.32 Flash Therapeutics
7.32.1 Flash Therapeutics Details
7.32.2 Flash Therapeutics Major Business
7.32.3 Flash Therapeutics Viral Vector CDMO Services Product and Services
7.32.4 Flash Therapeutics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.32.5 Flash Therapeutics Recent Developments/Updates
7.32.6 Flash Therapeutics Competitive Strengths & Weaknesses
7.33 VIVEBiotech
7.33.1 VIVEBiotech Details
7.33.2 VIVEBiotech Major Business
7.33.3 VIVEBiotech Viral Vector CDMO Services Product and Services
7.33.4 VIVEBiotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.33.5 VIVEBiotech Recent Developments/Updates
7.33.6 VIVEBiotech Competitive Strengths & Weaknesses
7.34 FinVector
7.34.1 FinVector Details
7.34.2 FinVector Major Business
7.34.3 FinVector Viral Vector CDMO Services Product and Services
7.34.4 FinVector Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.34.5 FinVector Recent Developments/Updates
7.34.6 FinVector Competitive Strengths & Weaknesses
7.35 uBriGene
7.35.1 uBriGene Details
7.35.2 uBriGene Major Business
7.35.3 uBriGene Viral Vector CDMO Services Product and Services
7.35.4 uBriGene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.35.5 uBriGene Recent Developments/Updates
7.35.6 uBriGene Competitive Strengths & Weaknesses
7.36 Eurogentec
7.36.1 Eurogentec Details
7.36.2 Eurogentec Major Business
7.36.3 Eurogentec Viral Vector CDMO Services Product and Services
7.36.4 Eurogentec Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.36.5 Eurogentec Recent Developments/Updates
7.36.6 Eurogentec Competitive Strengths & Weaknesses
7.37 VGXI
7.37.1 VGXI Details
7.37.2 VGXI Major Business
7.37.3 VGXI Viral Vector CDMO Services Product and Services
7.37.4 VGXI Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.37.5 VGXI Recent Developments/Updates
7.37.6 VGXI Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Vector CDMO Services Industry Chain
8.2 Viral Vector CDMO Services Upstream Analysis
8.3 Viral Vector CDMO Services Midstream Analysis
8.4 Viral Vector CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Viral Vector CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Viral Vector CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Viral Vector CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Viral Vector CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Viral Vector CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Viral Vector CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Viral Vector CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Viral Vector CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Viral Vector CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Viral Vector CDMO Services Players in 2022
Table 12. World Viral Vector CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Viral Vector CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Viral Vector CDMO Services Player
Table 15. Viral Vector CDMO Services Market: Company Product Type Footprint
Table 16. Viral Vector CDMO Services Market: Company Product Application Footprint
Table 17. Viral Vector CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Viral Vector CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Viral Vector CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Viral Vector CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Viral Vector CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Viral Vector CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Viral Vector CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Viral Vector CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Viral Vector CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Viral Vector CDMO Services Revenue Market Share (2018-2023)
Table 29. World Viral Vector CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Viral Vector CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Viral Vector CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Viral Vector CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Viral Vector CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Viral Vector CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Viral Vector CDMO Services Product and Services
Table 38. Thermo Fisher Scientific Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Lonza Basic Information, Area Served and Competitors
Table 42. Lonza Major Business
Table 43. Lonza Viral Vector CDMO Services Product and Services
Table 44. Lonza Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Recent Developments/Updates
Table 46. Lonza Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Viral Vector CDMO Services Product and Services
Table 50. Catalent Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Charles River Basic Information, Area Served and Competitors
Table 54. Charles River Major Business
Table 55. Charles River Viral Vector CDMO Services Product and Services
Table 56. Charles River Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Charles River Recent Developments/Updates
Table 58. Charles River Competitive Strengths & Weaknesses
Table 59. Merck Basic Information, Area Served and Competitors
Table 60. Merck Major Business
Table 61. Merck Viral Vector CDMO Services Product and Services
Table 62. Merck Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck Recent Developments/Updates
Table 64. Merck Competitive Strengths & Weaknesses
Table 65. SK pharmteco Basic Information, Area Served and Competitors
Table 66. SK pharmteco Major Business
Table 67. SK pharmteco Viral Vector CDMO Services Product and Services
Table 68. SK pharmteco Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. SK pharmteco Recent Developments/Updates
Table 70. SK pharmteco Competitive Strengths & Weaknesses
Table 71. Oxford Biomedica Basic Information, Area Served and Competitors
Table 72. Oxford Biomedica Major Business
Table 73. Oxford Biomedica Viral Vector CDMO Services Product and Services
Table 74. Oxford Biomedica Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Oxford Biomedica Recent Developments/Updates
Table 76. Oxford Biomedica Competitive Strengths & Weaknesses
Table 77. AGC Biologics?MolMed? Basic Information, Area Served and Competitors
Table 78. AGC Biologics?MolMed? Major Business
Table 79. AGC Biologics?MolMed? Viral Vector CDMO Services Product and Services
Table 80. AGC Biologics?MolMed? Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. AGC Biologics?MolMed? Recent Developments/Updates
Table 82. AGC Biologics?MolMed? Competitive Strengths & Weaknesses
Table 83. Gene Universal Basic Information, Area Served and Competitors
Table 84. Gene Universal Major Business
Table 85. Gene Universal Viral Vector CDMO Services Product and Services
Table 86. Gene Universal Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Gene Universal Recent Developments/Updates
Table 88. Gene Universal Competitive Strengths & Weaknesses
Table 89. Polyplus (Sartorius) Basic Information, Area Served and Competitors
Table 90. Polyplus (Sartorius) Major Business
Table 91. Polyplus (Sartorius) Viral Vector CDMO Services Product and Services
Table 92. Polyplus (Sartorius) Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Polyplus (Sartorius) Recent Developments/Updates
Table 94. Polyplus (Sartorius) Competitive Strengths & Weaknesses
Table 95. CCRM Basic Information, Area Served and Competitors
Table 96. CCRM Major Business
Table 97. CCRM Viral Vector CDMO Services Product and Services
Table 98. CCRM Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CCRM Recent Developments/Updates
Table 100. CCRM Competitive Strengths & Weaknesses
Table 101. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 102. FUJIFILM Diosynth Biotechnologies Major Business
Table 103. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Services
Table 104. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 106. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 107. Biovian Basic Information, Area Served and Competitors
Table 108. Biovian Major Business
Table 109. Biovian Viral Vector CDMO Services Product and Services
Table 110. Biovian Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Biovian Recent Developments/Updates
Table 112. Biovian Competitive Strengths & Weaknesses
Table 113. Miltenyi Bioindustry Basic Information, Area Served and Competitors
Table 114. Miltenyi Bioindustry Major Business
Table 115. Miltenyi Bioindustry Viral Vector CDMO Services Product and Services
Table 116. Miltenyi Bioindustry Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Miltenyi Bioindustry Recent Developments/Updates
Table 118. Miltenyi Bioindustry Competitive Strengths & Weaknesses
Table 119. Aldevron Basic Information, Area Served and Competitors
Table 120. Aldevron Major Business
Table 121. Aldevron Viral Vector CDMO Services Product and Services
Table 122. Aldevron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Aldevron Recent Developments/Updates
Table 124. Aldevron Competitive Strengths & Weaknesses
Table 125. Takara Bio Basic Information, Area Served and Competitors
Table 126. Takara Bio Major Business
Table 127. Takara Bio Viral Vector CDMO Services Product and Services
Table 128. Takara Bio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Takara Bio Recent Developments/Updates
Table 130. Takara Bio Competitive Strengths & Weaknesses
Table 131. Yposkesi Basic Information, Area Served and Competitors
Table 132. Yposkesi Major Business
Table 133. Yposkesi Viral Vector CDMO Services Product and Services
Table 134. Yposkesi Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Yposkesi Recent Developments/Updates
Table 136. Yposkesi Competitive Strengths & Weaknesses
Table 137. Genezen Basic Information, Area Served and Competitors
Table 138. Genezen Major Business
Table 139. Genezen Viral Vector CDMO Services Product and Services
Table 140. Genezen Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Genezen Recent Developments/Updates
Table 142. Genezen Competitive Strengths & Weaknesses
Table 143. GenScript ProBio Basic Information, Area Served and Competitors
Table 144. GenScript ProBio Major Business
Table 145. GenScript ProBio Viral Vector CDMO Services Product and Services
Table 146. GenScript ProBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. GenScript ProBio Recent Developments/Updates
Table 148. GenScript ProBio Competitive Strengths & Weaknesses
Table 149. EurekaBio Basic Information, Area Served and Competitors
Table 150. EurekaBio Major Business
Table 151. EurekaBio Viral Vector CDMO Services Product and Services
Table 152. EurekaBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. EurekaBio Recent Developments/Updates
Table 154. EurekaBio Competitive Strengths & Weaknesses
Table 155. Obio Technology Basic Information, Area Served and Competitors
Table 156. Obio Technology Major Business
Table 157. Obio Technology Viral Vector CDMO Services Product and Services
Table 158. Obio Technology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Obio Technology Recent Developments/Updates
Table 160. Obio Technology Competitive Strengths & Weaknesses
Table 161. GeneSail Biotech Basic Information, Area Served and Competitors
Table 162. GeneSail Biotech Major Business
Table 163. GeneSail Biotech Viral Vector CDMO Services Product and Services
Table 164. GeneSail Biotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. GeneSail Biotech Recent Developments/Updates
Table 166. GeneSail Biotech Competitive Strengths & Weaknesses
Table 167. VectorBuilder Basic Information, Area Served and Competitors
Table 168. VectorBuilder Major Business
Table 169. VectorBuilder Viral Vector CDMO Services Product and Services
Table 170. VectorBuilder Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. VectorBuilder Recent Developments/Updates
Table 172. VectorBuilder Competitive Strengths & Weaknesses
Table 173. WuXi ATU Basic Information, Area Served and Competitors
Table 174. WuXi ATU Major Business
Table 175. WuXi ATU Viral Vector CDMO Services Product and Services
Table 176. WuXi ATU Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. WuXi ATU Recent Developments/Updates
Table 178. WuXi ATU Competitive Strengths & Weaknesses
Table 179. Ubrigene Basic Information, Area Served and Competitors
Table 180. Ubrigene Major Business
Table 181. Ubrigene Viral Vector CDMO Services Product and Services
Table 182. Ubrigene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Ubrigene Recent Developments/Updates
Table 184. Ubrigene Competitive Strengths & Weaknesses
Table 185. Porton Biologics Basic Information, Area Served and Competitors
Table 186. Porton Biologics Major Business
Table 187. Porton Biologics Viral Vector CDMO Services Product and Services
Table 188. Porton Biologics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Porton Biologics Recent Developments/Updates
Table 190. Porton Biologics Competitive Strengths & Weaknesses
Table 191. Pharmaron Basic Information, Area Served and Competitors
Table 192. Pharmaron Major Business
Table 193. Pharmaron Viral Vector CDMO Services Product and Services
Table 194. Pharmaron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Pharmaron Recent Developments/Updates
Table 196. Pharmaron Competitive Strengths & Weaknesses
Table 197. PackGene Biotechnology Basic Information, Area Served and Competitors
Table 198. PackGene Biotechnology Major Business
Table 199. PackGene Biotechnology Viral Vector CDMO Services Product and Services
Table 200. PackGene Biotechnology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. PackGene Biotechnology Recent Developments/Updates
Table 202. PackGene Biotechnology Competitive Strengths & Weaknesses
Table 203. Hillgene Basic Information, Area Served and Competitors
Table 204. HillgeneMajor Business
Table 205. Hillgene Viral Vector CDMO Services Product and Services
Table 206. Hillgene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 207. Hillgene Recent Developments/Updates
Table 208. Hillgene Competitive Strengths & Weaknesses
Table 209. Asymchem Basic Information, Area Served and Competitors
Table 210. Asymchem Major Business
Table 211. Asymchem Viral Vector CDMO Services Product and Services
Table 212. Asymchem Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 213. Asymchem Recent Developments/Updates
Table 214. Asymchem Competitive Strengths & Weaknesses
Table 215. Exthera Basic Information, Area Served and Competitors
Table 216. Exthera Major Business
Table 217. Exthera Viral Vector CDMO Services Product and Services
Table 218. Exthera Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 219. Exthera Recent Developments/Updates
Table 220. Exthera Competitive Strengths & Weaknesses
Table 221. Flash Therapeutics Basic Information, Area Served and Competitors
Table 222. Flash Therapeutics Major Business
Table 223. Flash Therapeutics Viral Vector CDMO Services Product and Services
Table 224. Flash Therapeutics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 225. Flash Therapeutics Recent Developments/Updates
Table 226. Flash Therapeutics Competitive Strengths & Weaknesses
Table 227. VIVEBiotech Basic Information, Area Served and Competitors
Table 228. VIVEBiotech Major Business
Table 229. VIVEBiotech Viral Vector CDMO Services Product and Services
Table 230. VIVEBiotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 231. VIVEBiotech Recent Developments/Updates
Table 232. VIVEBiotech Competitive Strengths & Weaknesses
Table 233. FinVector Basic Information, Area Served and Competitors
Table 234. FinVector Major Business
Table 235. FinVector Viral Vector CDMO Services Product and Services
Table 236. FinVector Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 237. FinVector Recent Developments/Updates
Table 238. FinVector Competitive Strengths & Weaknesses
Table 239. uBriGene Basic Information, Area Served and Competitors
Table 240. uBriGene Major Business
Table 241. uBriGene Viral Vector CDMO Services Product and Services
Table 242. uBriGene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 243. uBriGene Recent Developments/Updates
Table 244. uBriGene Competitive Strengths & Weaknesses
Table 245. Eurogentec Basic Information, Area Served and Competitors
Table 246. Eurogentec Major Business
Table 247. Eurogentec Viral Vector CDMO Services Product and Services
Table 248. Eurogentec Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 249. Eurogentec Recent Developments/Updates
Table 250. VGXI Basic Information, Area Served and Competitors
Table 251. VGXI Major Business
Table 252. VGXI Viral Vector CDMO Services Product and Services
Table 253. VGXI Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 254. Global Key Players of Viral Vector CDMO Services Upstream (Raw Materials)
Table 255. Viral Vector CDMO Services Typical Customers
LIST OF FIGURE
Figure 1. Viral Vector CDMO Services Picture
Figure 2. World Viral Vector CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viral Vector CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Viral Vector CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Viral Vector CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Viral Vector CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Viral Vector CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Viral Vector CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Viral Vector CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Viral Vector CDMO Services Markets in 2022
Figure 27. United States VS China: Viral Vector CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viral Vector CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Viral Vector CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Viral Vector CDMO Services Market Size Market Share by Type in 2022
Figure 31. AAV
Figure 32. Lentivirus
Figure 33. Adenovirus
Figure 34. HSV
Figure 35. Others
Figure 36. World Viral Vector CDMO Services Market Size Market Share by Type (2018-2029)
Figure 37. World Viral Vector CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Viral Vector CDMO Services Market Size Market Share by Application in 2022
Figure 39. Vaccine Development
Figure 40. Gene Therapy
Figure 41. Academic Scientific Research Institution
Figure 42. Others
Figure 43. Viral Vector CDMO Services Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Table 1. World Viral Vector CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Viral Vector CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Viral Vector CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Viral Vector CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Viral Vector CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Viral Vector CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Viral Vector CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Viral Vector CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Viral Vector CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Viral Vector CDMO Services Players in 2022
Table 12. World Viral Vector CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Viral Vector CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Viral Vector CDMO Services Player
Table 15. Viral Vector CDMO Services Market: Company Product Type Footprint
Table 16. Viral Vector CDMO Services Market: Company Product Application Footprint
Table 17. Viral Vector CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Viral Vector CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Viral Vector CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Viral Vector CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Viral Vector CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Viral Vector CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Viral Vector CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Viral Vector CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Viral Vector CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Viral Vector CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Viral Vector CDMO Services Revenue Market Share (2018-2023)
Table 29. World Viral Vector CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Viral Vector CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Viral Vector CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Viral Vector CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Viral Vector CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Viral Vector CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Viral Vector CDMO Services Product and Services
Table 38. Thermo Fisher Scientific Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Lonza Basic Information, Area Served and Competitors
Table 42. Lonza Major Business
Table 43. Lonza Viral Vector CDMO Services Product and Services
Table 44. Lonza Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Recent Developments/Updates
Table 46. Lonza Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Viral Vector CDMO Services Product and Services
Table 50. Catalent Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Charles River Basic Information, Area Served and Competitors
Table 54. Charles River Major Business
Table 55. Charles River Viral Vector CDMO Services Product and Services
Table 56. Charles River Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Charles River Recent Developments/Updates
Table 58. Charles River Competitive Strengths & Weaknesses
Table 59. Merck Basic Information, Area Served and Competitors
Table 60. Merck Major Business
Table 61. Merck Viral Vector CDMO Services Product and Services
Table 62. Merck Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck Recent Developments/Updates
Table 64. Merck Competitive Strengths & Weaknesses
Table 65. SK pharmteco Basic Information, Area Served and Competitors
Table 66. SK pharmteco Major Business
Table 67. SK pharmteco Viral Vector CDMO Services Product and Services
Table 68. SK pharmteco Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. SK pharmteco Recent Developments/Updates
Table 70. SK pharmteco Competitive Strengths & Weaknesses
Table 71. Oxford Biomedica Basic Information, Area Served and Competitors
Table 72. Oxford Biomedica Major Business
Table 73. Oxford Biomedica Viral Vector CDMO Services Product and Services
Table 74. Oxford Biomedica Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Oxford Biomedica Recent Developments/Updates
Table 76. Oxford Biomedica Competitive Strengths & Weaknesses
Table 77. AGC Biologics?MolMed? Basic Information, Area Served and Competitors
Table 78. AGC Biologics?MolMed? Major Business
Table 79. AGC Biologics?MolMed? Viral Vector CDMO Services Product and Services
Table 80. AGC Biologics?MolMed? Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. AGC Biologics?MolMed? Recent Developments/Updates
Table 82. AGC Biologics?MolMed? Competitive Strengths & Weaknesses
Table 83. Gene Universal Basic Information, Area Served and Competitors
Table 84. Gene Universal Major Business
Table 85. Gene Universal Viral Vector CDMO Services Product and Services
Table 86. Gene Universal Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Gene Universal Recent Developments/Updates
Table 88. Gene Universal Competitive Strengths & Weaknesses
Table 89. Polyplus (Sartorius) Basic Information, Area Served and Competitors
Table 90. Polyplus (Sartorius) Major Business
Table 91. Polyplus (Sartorius) Viral Vector CDMO Services Product and Services
Table 92. Polyplus (Sartorius) Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Polyplus (Sartorius) Recent Developments/Updates
Table 94. Polyplus (Sartorius) Competitive Strengths & Weaknesses
Table 95. CCRM Basic Information, Area Served and Competitors
Table 96. CCRM Major Business
Table 97. CCRM Viral Vector CDMO Services Product and Services
Table 98. CCRM Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CCRM Recent Developments/Updates
Table 100. CCRM Competitive Strengths & Weaknesses
Table 101. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 102. FUJIFILM Diosynth Biotechnologies Major Business
Table 103. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Services
Table 104. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 106. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 107. Biovian Basic Information, Area Served and Competitors
Table 108. Biovian Major Business
Table 109. Biovian Viral Vector CDMO Services Product and Services
Table 110. Biovian Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Biovian Recent Developments/Updates
Table 112. Biovian Competitive Strengths & Weaknesses
Table 113. Miltenyi Bioindustry Basic Information, Area Served and Competitors
Table 114. Miltenyi Bioindustry Major Business
Table 115. Miltenyi Bioindustry Viral Vector CDMO Services Product and Services
Table 116. Miltenyi Bioindustry Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Miltenyi Bioindustry Recent Developments/Updates
Table 118. Miltenyi Bioindustry Competitive Strengths & Weaknesses
Table 119. Aldevron Basic Information, Area Served and Competitors
Table 120. Aldevron Major Business
Table 121. Aldevron Viral Vector CDMO Services Product and Services
Table 122. Aldevron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Aldevron Recent Developments/Updates
Table 124. Aldevron Competitive Strengths & Weaknesses
Table 125. Takara Bio Basic Information, Area Served and Competitors
Table 126. Takara Bio Major Business
Table 127. Takara Bio Viral Vector CDMO Services Product and Services
Table 128. Takara Bio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Takara Bio Recent Developments/Updates
Table 130. Takara Bio Competitive Strengths & Weaknesses
Table 131. Yposkesi Basic Information, Area Served and Competitors
Table 132. Yposkesi Major Business
Table 133. Yposkesi Viral Vector CDMO Services Product and Services
Table 134. Yposkesi Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Yposkesi Recent Developments/Updates
Table 136. Yposkesi Competitive Strengths & Weaknesses
Table 137. Genezen Basic Information, Area Served and Competitors
Table 138. Genezen Major Business
Table 139. Genezen Viral Vector CDMO Services Product and Services
Table 140. Genezen Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Genezen Recent Developments/Updates
Table 142. Genezen Competitive Strengths & Weaknesses
Table 143. GenScript ProBio Basic Information, Area Served and Competitors
Table 144. GenScript ProBio Major Business
Table 145. GenScript ProBio Viral Vector CDMO Services Product and Services
Table 146. GenScript ProBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. GenScript ProBio Recent Developments/Updates
Table 148. GenScript ProBio Competitive Strengths & Weaknesses
Table 149. EurekaBio Basic Information, Area Served and Competitors
Table 150. EurekaBio Major Business
Table 151. EurekaBio Viral Vector CDMO Services Product and Services
Table 152. EurekaBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. EurekaBio Recent Developments/Updates
Table 154. EurekaBio Competitive Strengths & Weaknesses
Table 155. Obio Technology Basic Information, Area Served and Competitors
Table 156. Obio Technology Major Business
Table 157. Obio Technology Viral Vector CDMO Services Product and Services
Table 158. Obio Technology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Obio Technology Recent Developments/Updates
Table 160. Obio Technology Competitive Strengths & Weaknesses
Table 161. GeneSail Biotech Basic Information, Area Served and Competitors
Table 162. GeneSail Biotech Major Business
Table 163. GeneSail Biotech Viral Vector CDMO Services Product and Services
Table 164. GeneSail Biotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. GeneSail Biotech Recent Developments/Updates
Table 166. GeneSail Biotech Competitive Strengths & Weaknesses
Table 167. VectorBuilder Basic Information, Area Served and Competitors
Table 168. VectorBuilder Major Business
Table 169. VectorBuilder Viral Vector CDMO Services Product and Services
Table 170. VectorBuilder Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. VectorBuilder Recent Developments/Updates
Table 172. VectorBuilder Competitive Strengths & Weaknesses
Table 173. WuXi ATU Basic Information, Area Served and Competitors
Table 174. WuXi ATU Major Business
Table 175. WuXi ATU Viral Vector CDMO Services Product and Services
Table 176. WuXi ATU Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. WuXi ATU Recent Developments/Updates
Table 178. WuXi ATU Competitive Strengths & Weaknesses
Table 179. Ubrigene Basic Information, Area Served and Competitors
Table 180. Ubrigene Major Business
Table 181. Ubrigene Viral Vector CDMO Services Product and Services
Table 182. Ubrigene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Ubrigene Recent Developments/Updates
Table 184. Ubrigene Competitive Strengths & Weaknesses
Table 185. Porton Biologics Basic Information, Area Served and Competitors
Table 186. Porton Biologics Major Business
Table 187. Porton Biologics Viral Vector CDMO Services Product and Services
Table 188. Porton Biologics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Porton Biologics Recent Developments/Updates
Table 190. Porton Biologics Competitive Strengths & Weaknesses
Table 191. Pharmaron Basic Information, Area Served and Competitors
Table 192. Pharmaron Major Business
Table 193. Pharmaron Viral Vector CDMO Services Product and Services
Table 194. Pharmaron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Pharmaron Recent Developments/Updates
Table 196. Pharmaron Competitive Strengths & Weaknesses
Table 197. PackGene Biotechnology Basic Information, Area Served and Competitors
Table 198. PackGene Biotechnology Major Business
Table 199. PackGene Biotechnology Viral Vector CDMO Services Product and Services
Table 200. PackGene Biotechnology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. PackGene Biotechnology Recent Developments/Updates
Table 202. PackGene Biotechnology Competitive Strengths & Weaknesses
Table 203. Hillgene Basic Information, Area Served and Competitors
Table 204. HillgeneMajor Business
Table 205. Hillgene Viral Vector CDMO Services Product and Services
Table 206. Hillgene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 207. Hillgene Recent Developments/Updates
Table 208. Hillgene Competitive Strengths & Weaknesses
Table 209. Asymchem Basic Information, Area Served and Competitors
Table 210. Asymchem Major Business
Table 211. Asymchem Viral Vector CDMO Services Product and Services
Table 212. Asymchem Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 213. Asymchem Recent Developments/Updates
Table 214. Asymchem Competitive Strengths & Weaknesses
Table 215. Exthera Basic Information, Area Served and Competitors
Table 216. Exthera Major Business
Table 217. Exthera Viral Vector CDMO Services Product and Services
Table 218. Exthera Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 219. Exthera Recent Developments/Updates
Table 220. Exthera Competitive Strengths & Weaknesses
Table 221. Flash Therapeutics Basic Information, Area Served and Competitors
Table 222. Flash Therapeutics Major Business
Table 223. Flash Therapeutics Viral Vector CDMO Services Product and Services
Table 224. Flash Therapeutics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 225. Flash Therapeutics Recent Developments/Updates
Table 226. Flash Therapeutics Competitive Strengths & Weaknesses
Table 227. VIVEBiotech Basic Information, Area Served and Competitors
Table 228. VIVEBiotech Major Business
Table 229. VIVEBiotech Viral Vector CDMO Services Product and Services
Table 230. VIVEBiotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 231. VIVEBiotech Recent Developments/Updates
Table 232. VIVEBiotech Competitive Strengths & Weaknesses
Table 233. FinVector Basic Information, Area Served and Competitors
Table 234. FinVector Major Business
Table 235. FinVector Viral Vector CDMO Services Product and Services
Table 236. FinVector Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 237. FinVector Recent Developments/Updates
Table 238. FinVector Competitive Strengths & Weaknesses
Table 239. uBriGene Basic Information, Area Served and Competitors
Table 240. uBriGene Major Business
Table 241. uBriGene Viral Vector CDMO Services Product and Services
Table 242. uBriGene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 243. uBriGene Recent Developments/Updates
Table 244. uBriGene Competitive Strengths & Weaknesses
Table 245. Eurogentec Basic Information, Area Served and Competitors
Table 246. Eurogentec Major Business
Table 247. Eurogentec Viral Vector CDMO Services Product and Services
Table 248. Eurogentec Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 249. Eurogentec Recent Developments/Updates
Table 250. VGXI Basic Information, Area Served and Competitors
Table 251. VGXI Major Business
Table 252. VGXI Viral Vector CDMO Services Product and Services
Table 253. VGXI Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 254. Global Key Players of Viral Vector CDMO Services Upstream (Raw Materials)
Table 255. Viral Vector CDMO Services Typical Customers
LIST OF FIGURE
Figure 1. Viral Vector CDMO Services Picture
Figure 2. World Viral Vector CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viral Vector CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Viral Vector CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Viral Vector CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Viral Vector CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Viral Vector CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Viral Vector CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Viral Vector CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Viral Vector CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Viral Vector CDMO Services Markets in 2022
Figure 27. United States VS China: Viral Vector CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viral Vector CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Viral Vector CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Viral Vector CDMO Services Market Size Market Share by Type in 2022
Figure 31. AAV
Figure 32. Lentivirus
Figure 33. Adenovirus
Figure 34. HSV
Figure 35. Others
Figure 36. World Viral Vector CDMO Services Market Size Market Share by Type (2018-2029)
Figure 37. World Viral Vector CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Viral Vector CDMO Services Market Size Market Share by Application in 2022
Figure 39. Vaccine Development
Figure 40. Gene Therapy
Figure 41. Academic Scientific Research Institution
Figure 42. Others
Figure 43. Viral Vector CDMO Services Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
